// App-Quantinova.ai

7028 : Clinical utility of whole genome sequencing in hematological neoplasms.

Researchers

Presenter

  • Jesus Gutierrez-Abril

Principal Investigators

  • Yangyu Zhou

  • SooWah Lee

  • Max Levine

  • Juan E. Arango Ossa

  • Gunes Gundem

  • Juan Medina-Martinez

  • Rachel Mitchell

  • Amy A. Kirkwood

  • Laura Clifton-Hadley

  • Pip Patrick

  • Bela Wrench

  • Andrew Kung

  • Maria Luisa Sulis

  • Neerav Shukla

  • Anthony Moorman

  • Adele K. Fielding

  • Elli Papaemmanuil

Medical Centers

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Wellcome Trust Sanger Institute, Cambridge, United Kingdom

  • Tempus Labs, New York City, NY

  • Bart's Cancer Institute, London, United Kingdom

  • Department of Haematology, UCL Cancer Institute, London, United Kingdom

  • Cancer Research UK & UCL Cancer Trials Centre, University College London, UK

  • NCRI, London, United Kingdom

  • Cancer Research UK and UCL Cancer Trials Centre, University College London, London, United Kingdom

  • Barts Cancer Institute, Queen Mary University of London, London, United Kingdom

  • Leukemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne, United Kingdom

  • Department of Hematology, University College London Medical School, Royal Free Campus, London, United Kingdom

  • Sloan Kettering Institute, New York, NY

Locations

  • United States

  • United Kingdom

Companies

  • Wellcome Sanger Inst

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • B-cell acute lymphoblastic leukemia

  • T-cell acute lymphoblastic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • EP300

Outcome

  • N/A


Study Design

  • N/A

Phase

  • N/A

Study Id's

  • NCT01085617

Sponsors

  • N/A

Result

  • N/A